Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Free Report)’s stock price fell 0.4% during trading on Monday . The stock traded as low as $39.79 and last traded at $39.80. 13,881 shares were traded during trading, a decline of 62% from the average session volume of 36,826 shares. The stock had previously closed at $39.95.
Virtus LifeSci Biotech Clinical Trials ETF Stock Down 0.4%
The stock’s fifty day simple moving average is $33.36 and its two-hundred day simple moving average is $26.16.
Virtus LifeSci Biotech Clinical Trials ETF Company Profile
The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.
Further Reading
- Five stocks we like better than Virtus LifeSci Biotech Clinical Trials ETF
- With Risk Tolerance, One Size Does Not Fit All
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
- Growth Stocks: What They Are, Examples and How to Invest
- Dell and HP Are Raising Prices—And Investors Should Take Note
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026
Receive News & Ratings for Virtus LifeSci Biotech Clinical Trials ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and related companies with MarketBeat.com's FREE daily email newsletter.
